Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenue $ 8,882 $ 13,917
Cost of revenue 3,812 7,153
Gross profit 5,070 6,764
Operating expenses:    
Sales and marketing 7,752 11,398
Research and development 2,474 4,596
General and administrative 7,702 7,409
Impairment of goodwill 189 0
Restructuring 244 0
Total operating expenses 18,361 23,403
Loss from operations (13,291) (16,639)
Other (expense) income, net:    
Interest expense (139) (384)
Finance cost associated with warrant issuance (329) (1,096)
(Loss) gain on warrant liabilities (3,056) 6,376
Loss on modification of warrants 0 (257)
Other income (expense), net 990 (132)
Total other (expense) income, net (2,534) 4,507
Net loss (15,825) (12,132)
Foreign currency translation adjustments (897) 142
Comprehensive loss $ (16,722) $ (11,990)
Basic and diluted net loss per share applicable to common shareholders (in dollars per share) $ (2.21) $ (2.53)
Weighted average number of shares outstanding, basic and diluted (in shares) 7,164 4,794